United Therapeutics | UTHR - Ordinary Share Capital

Stock Price
467.74
Daily Change
-5.68 -1.20%
Monthly
-1.19%
Yearly
30.58%
Q1 Forecast
458.74

United Therapeutics reported $42.9M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Amarin USD 20.8M 28K Sep/2025
Ardelyx USD 238.02M 1.13M Dec/2024
Baxter International USD 514.28M 168.72M Dec/2025
Bayer EUR 982.42M 0 Sep/2025
BioCryst Pharmaceuticals USD 1.9M 3K Sep/2023
Biogen USD 146.7M 200K Sep/2025
BioMarin Pharmaceutical USD 192.1M 97K Sep/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Esperion Therapeutics USD 112K 11K Sep/2023
Gilead Sciences USD 1.24B 1000K Dec/2025
GlaxoSmithKline GBP 4.08B 49.43M Dec/2025
Halozyme Therapeutics USD 117.78M 259K Dec/2025
Insmed USD 214.26M 1.67M Dec/2025
Ionis Pharmaceuticals USD 161.14M 160.98M Sep/2025
J&J USD 2.41B 584K Sep/2025
Moderna USD 391M 2M Sep/2025
Omeros USD 611K 17K Dec/2023
Pfizer USD 5.69B 1000K Sep/2025
PTC Therapeutics USD 81.47M 1.54M Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Sarepta Therapeutics USD 104.77M 7.06M Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025
United Therapeutics USD 42.9M 42.1M Sep/2025
Vertex Pharmaceuticals USD 254M 0 Dec/2025